Case report of acute encephalitis following the AstraZeneca COVID-19 vaccine.

Authors :: Li SY
Chen HH
Liu PY
Shi ZY
Lin YH
Tsai CA
Lin SP
Source :: International journal of rheumatic diseases [Int J Rheum Dis] 2022 Aug; Vol. 25 (8), pp. 950-956. Date of Electronic Publication: 2022 Jun 23.
Publication Year :: 2022
Abstract: Coronavirus disease 2019 (COVID-19) vaccines have proven to be safe, effective and life-saving. However, little information is available on the neurological complications of COVID-19 vaccine. Here, we report a case who developed acute encephalomyelitis 1 week after being vaccinated with AstraZeneca COVID-19 vaccine (AZ vaccine). Autoimmune/inflammatory syndrome induced by adjuvants (ASIA) was also suspected. After intravenous dexamethasone and subcutaneous fondaparinux therapy, he returned to normal life without neurological sequelae. Four months later, he received Moderna COVID-19 vaccine without any sequelae.<br /> (© 2022 Asia Pacific League of Associations for Rheumatology and John Wiley & Sons Australia, Ltd.)